Browse All

Current Filters

CLEAR FILTER x

TITLE

Subcortical Brain Volume is Associated With Patient-related Measures of Working Memory Maintenance in Multiple Sclerosis

Author:Rajan, Laya   Sumowski, James   Katz Sand, Ilana   

Session Name:P3: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 3  

Topic:Multiple Sclerosis  

Program Number:P3.006  

Author Institution:Icahn School of Medicine at Mount Sinai, Manhattan, NY  Icahn School of Medicine At Mount Sinai, New York, NY  Corinne Goldsmith Dickinson Center for MS, New York, NY  

Subcortical Gray Matter Atrophy in Multiple Sclerosis: A Comparison Between RRMS and PMS Subtypes

Author:Celenk, Berat Goksu   Allahverdi, Fuad   Koc, Onur   Sunal, Baran Serdar   Unal, Aysun   

Session Name:P8: Multiple Sclerosis: Imaging 2  

Topic:Multiple Sclerosis  

Program Number:P8.008  

Author Institution:Namik Kemal University, Tekirdag, Turkey, Tekirdag, Turkey  

Subgroup Analyses of the Phase Three Tolebrutinib in Non-relapsing Secondary Progressive Multiple Sclerosis (nrSPMS) HERCULES Trial

Author:Fox, Robert J.   Bar-Or, Amit   Traboulsee, Anthony   Oreja-Guevara, Celia   Giovannoni, Gavin   Vermersch, Patrick   Syed, Sana   Li, Ye   Vargas, Wendy S.   Turner, Timothy J.   Wallstroem, Erik   Reich, Daniel S.   

Session Name:P7: Multiple Sclerosis: Clinical Trials 1  

Topic:Multiple Sclerosis  

Program Number:P7.004  

Author Institution:Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, United States, OH  Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, University of Pennsylvania, Philadelphia, United States, PA  The University of British Columbia, Division of Neurology, Vancouver, Canada, BC, Canada  Departamento de Neurologia, Hospital Clinico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain  Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain, Spain  Queen Mary University London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom, United Kingdom  University of Lille, Inserm U1172, CHU Lille, FHU Precise, Lille, France, France  Sanofi, Cambridge, United States, MA  Sanofi, Bridgewater, United States, MA  Translational Neuroradiology Section, National Institutes of Health, Bethesda, United States, MD  

Subgroup Analysis of the Phase Three Tolebrutinib HERCULES Trial: Disability Accumulation Outcomes in North American Participants

Author:Coyle, Patricia   Bar-Or, Amit   Reich, Daniel   Traboulsee, Anthony   Syed, Sana   Li, Ye   Vargas, Wendy   Fox, Robert   

Session Name:P9: Multiple Sclerosis: Clinical Trials 2  

Topic:Multiple Sclerosis  

Program Number:P9.003  

Author Institution:Stony Brook University Renaissance School of Medicine, Stony Brook, NY  University of Pennsylvania, Philadelphia, PA  Translational Neuroradiology Section, National Institutes of Health, Bethesda, MD  University of British Columbia, Vancouver, BC, Canada  Sanofi, Cambridge, MA  Sanofi, Bridgewater, NJ  Cleveland Clinic, Cleveland, OH  

Subjective and Objective Findings of Anosmia are Discordant and Persist for Six Months in Hospitalized Individuals With Traumatic Brain Injury

Author:McCutcheon, Trevor   Desprebiteres, Justin   Erich, Amber   Deppen, Kate   Darnley, Stefanie   Sandsmark, Danielle   Diaz-Arrastia, Ramon   Kamath, Vidyulata   Ware, Jeffrey   Schneider, Andrea   Walter, Alexa   

Session Name:P3: Neuro Trauma and Sports Neurology: Clinical Management  

Topic:Neuro Trauma and Sports Neurology  

Program Number:P3.007  

Author Institution:University of Pennsylvania, New Hope, PA  University of Pennsylvania, PA  University of Pennsylvania, Philadelphia, PA  Johns Hopkins University, MD